Literature DB >> 1426308

Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age.

A C Pearlstone1, N Fournet, J C Gambone, S C Pang, R P Buyalos.   

Abstract

OBJECTIVES: To determine pregnancy and livebirth rates for women age 40 and older undergoing ovulation induction and to assess the impact of basal follicle-stimulating hormone (FSH) on outcome in these patients.
DESIGN: Prospective, observational.
SETTING: Fertility service of university medical center. PATIENTS: Infertile couples in whom the female partner was age 40 or older referred for ovulation induction therapy. INTERVENTION: Assessment of basal hormonal status; ovulation induction. MAIN OUTCOME MEASURES: Clinical pregnancy rate (PR), livebirth rate.
RESULTS: Analysis of 402 cycles in 85 women age 40 and older demonstrated a clinical PR of 3.5% per cycle (95% confidence interval [CI] 1.7% to 5.3%). The livebirth rate was 1.2% per cycle (95% CI 0.1% to 2.3%). Women with a basal FSH < 25 IU/L and age < 44 years had a clinical PR of 5.2% per cycle (95% CI 2.5% to 7.9%) compared with 0.0% per cycle (95% CI 0.0% to 2.1%) in cases in which either basal FSH was > or = 25 IU/L or age was > or = 44 (P < 0.005). The prognostic importance of basal FSH and chronological age was confirmed by multivariate logistic regression analysis. The predictive value of the resulting regression equation was high (R2 = 0.94; P < 0.01).
CONCLUSIONS: Pregnancy and livebirth rates are generally low during ovulation induction in women age 40 and older. In combination, basal FSH and chronological age are accurate predictors of PR, in these couples and can define a subset of patients with a more favorable prognosis. The spontaneous abortion rate in women who do conceive is high, substantially lowering the livebirth rate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426308     DOI: 10.1016/s0015-0282(16)55310-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Impact of body mass index on in vitro fertilization outcomes.

Authors:  John L Frattarelli; Catherine Lee Kodama
Journal:  J Assist Reprod Genet       Date:  2004-06       Impact factor: 3.412

2.  Body mass index, follicle-stimulating hormone and their predictive value in in vitro fertilization.

Authors:  Kathrin Ferlitsch; Michael O Sator; Doris M Gruber; Ernst Rücklinger; Christian J Gruber; Johannes C Huber
Journal:  J Assist Reprod Genet       Date:  2004-12       Impact factor: 3.412

3.  Fertility treatment in the forty and older woman.

Authors:  A Auyeung; M E Klein; V S Ratts; R R Odem; D B Williams
Journal:  J Assist Reprod Genet       Date:  2001-12       Impact factor: 3.412

4.  The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization.

Authors:  A H Watt; A T Legedza; E S Ginsburg; R L Barbieri; R N Clarke; M D Hornstein
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

5.  The combined effect of age and basal follicle-stimulating hormone on the cost of a live birth at assisted reproductive technology.

Authors:  Melinda B Henne; Barbara J Stegmann; Adrienne B Neithardt; William H Catherino; Alicia Y Armstrong; Tzu-Cheg Kao; James H Segars
Journal:  Fertil Steril       Date:  2007-07-31       Impact factor: 7.329

6.  Body mass index impacts in vitro fertilization stimulation.

Authors:  Micah J Hill; Steve Hong; John L Frattarelli
Journal:  ISRN Obstet Gynecol       Date:  2010-10-27

Review 7.  Aging and reproductive potential in women.

Authors:  C Fitzgerald; A E Zimon; E E Jones
Journal:  Yale J Biol Med       Date:  1998 Sep-Oct

Review 8.  Application of Stem Cell Therapy for Infertility.

Authors:  Sarama Saha; Partha Roy; Cynthia Corbitt; Sham S Kakar
Journal:  Cells       Date:  2021-06-28       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.